期刊
MOLECULAR NEUROBIOLOGY
卷 54, 期 3, 页码 1967-1977出版社
SPRINGER
DOI: 10.1007/s12035-016-9802-9
关键词
Alzheimer's disease (AD); beta-Site amyloid precursor protein cleavage enzyme 1 ( BACE1); Curcumin; beta-Amyloid protein ( A beta)
资金
- National Natural Science Foundation of China [91232709, 811171216, 81110555, 81401149]
- National and Fujian Province's Key Clinical Specialty Discipline Construction Programs
Alzheimer's disease (AD) is the most common dementia and the trigger of its pathological cascade is widely believed to be the overproduction and accumulation of beta-amyloid protein (A beta) in the affected brain. However, effective AD remedies are still anxiously awaited. Recent evidence suggests that curcumin may be a potential agent for AD treatment. In this study, we used 5xFAD transgenic mice as an AD model to investigate the effects of curcumin on AD. Our results showed that curcumin administration (150 or 300 mg/kg/day, intragastrically, for 60 days) dramatically reduced A beta production by downregulating BACE1 expression, preventing synaptic degradation, and improving spatial learning and memory impairment of 5xFAD mice. These findings suggest that curcumin is a potential candidate for AD treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据